BioSpace News Archive

Protembis GmbH announced the appointment of highly experienced and successful serial entrepreneur and medical device executive Azin Parhizgar as an Independent Member and Chairwoman of the Board of Directors.

Valbiotis announces its results for the first half of 2022 and provides an update on its developments since the beginning of the year.

Select Medical announced that 16 of its inpatient rehabilitation hospitals have been named to Newsweek’s 2022 list of America’s Best Physical Rehab Centers.

On September 13-14, 2022 the National Drowning Prevention Alliance (NDPA.org) hosted the industry’s first research summit solely dedicated to water safety and drowning prevention for children and adolescents - a critical issue and the single leading cause of death among children ages 1-4 years old.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced publication of peer-reviewed data detailing the discovery and preclinical profiling of antibodies from the Sorrento G-MAB™ library with neutralizing activity against SARS-CoV-2 in vitro and in vivo in Scientific Reports, a Nature portfolio journal.

The American Cancer Society has awarded Montefiore Einstein Cancer Center more than $2.1 million to support cancer research and reduce individual and systematic barriers that prevent people from accessing cancer care.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced an oral presentation by Dr. Atul Patel, JUNIPER clinical investigator, will take place on Friday, September 16 at 2:30 pm GMT+ 2 at the International Congress of Parkinson’s Disease and Movement Disorders (MDS Congress) in Madrid, Spain.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29, 2022 beginning at 12:00 p.m. ET.

Medcura Inc. welcomes Steve Ford, its new Senior Vice President of Marketing and Business Development, whose two-plus decades of experience leading and contributing to over 75 product development teams, and launching more than 100 medical devices globally, helps position the commercial-stage life science and medical device company for broad market adoption and rapid platform expansion.

Medtronic plc announced that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A., has priced an offering of €500,000,000 principal amount of 2.625% senior notes due 2025, €1,000,000,000 principal amount of 3.000% senior notes due 2028, €1,000,000,000 principal amount of 3.125% senior notes due 2031 and €1,000,000,000 principal amount of 3.375% senior notes due 2034.